During the past decade, Legacy Salmon Creek Hospital conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 47 clinical trials were completed, i.e. on average, 72.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 31 clinical trials were completed. i.e. 134.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Salmon Creek Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "NRG Oncology" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Salmon Creek Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Salmon Creek Hospital" are "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Legacy Salmon Creek Hospital" in a lesser frequency.

Most popular intervention types in "Legacy Salmon Creek Hospital" are "Drug" (83 trials), "Other" (77 trials), "Biological" (35 trials), "Radiation" (35 trials) and "Procedure" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (32 trials), "Questionnaire Administration" (20 trials), "Paclitaxel" (14 trials) and "Cisplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Salmon Creek Hospital" are 76 trials for "All" genders, 27 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Legacy Salmon Creek Hospital". undefined are not yet recruiting, 21 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Legacy Salmon Creek Hospital, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Salmon Creek Hospital, 4 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".